|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-1-4939-1501-9 |
003 |
DE-He213 |
005 |
20220117111026.0 |
007 |
cr nn 008mamaa |
008 |
140913s2015 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781493915019
|9 978-1-4939-1501-9
|
024 |
7 |
|
|a 10.1007/978-1-4939-1501-9
|2 doi
|
050 |
|
4 |
|a RC870-923.2
|
072 |
|
7 |
|a MJS
|2 bicssc
|
072 |
|
7 |
|a MED088000
|2 bisacsh
|
072 |
|
7 |
|a MJS
|2 thema
|
082 |
0 |
4 |
|a 616.6
|2 23
|
245 |
1 |
0 |
|a Upper Tract Urothelial Carcinoma
|h [electronic resource] /
|c edited by Shahrokh F. Shariat, Evanguelos Xylinas.
|
250 |
|
|
|a 1st ed. 2015.
|
264 |
|
1 |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2015.
|
300 |
|
|
|a XI, 198 p. 36 illus., 33 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Epidemiology and risk factors for upper urinary urothelial cancers -- Diagnosis and Evaluation of Upper Tract Urothelial Carcinoma (UTUC) -- Upper Urinary Tract Urothelial Carcinoma Pathology -- Prognostics factors, molecular markers and predictive tools in upper tract urothelial carcinoma -- Conservative management of low-risk UTUC -- Surgical Management of High-risk Upper Tract Urothelial Carcinoma -- The Role of Lymphadenectomy in the Management of Urothelial Carcinoma of the Upper Urinary Tract -- Chemotherapy.
|
520 |
|
|
|a Upper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. Its aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage andpatient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy are covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC. Upper Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists, and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology.
|
650 |
|
0 |
|a Urology.
|
650 |
|
0 |
|a Oncology.
|
650 |
1 |
4 |
|a Urology.
|
650 |
2 |
4 |
|a Oncology.
|
700 |
1 |
|
|a Shariat, Shahrokh F.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Xylinas, Evanguelos.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9781493915002
|
776 |
0 |
8 |
|i Printed edition:
|z 9781493915026
|
776 |
0 |
8 |
|i Printed edition:
|z 9781493947379
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-1-4939-1501-9
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|